Remove Pharma Companies Remove Regulation Remove Vaccination Remove Vaccine
article thumbnail

Vaccine issues already?

World of DTC Marketing

Pfizer is having supplier issues, some people who received the vaccine are reporting side effects like Bell’s Palsy. In the meantime this administration is patting itself on the back for the quick development of vaccines. What assurances does the public have that every dose of vaccine is made to the highest quality standards?

article thumbnail

Can J&J’s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? billion in penalties.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs.

article thumbnail

GSK’s Maria Reyes Boceta-Muñoz Talks Vaccine Development in a Post-Pandemic World

XTalks

Vaccines have been an integral piece of the global public health toolbox for over 200 years, but the COVID-19 pandemic brought about a new era in vaccine development with renewed interest in mRNA technology and unprecedented accelerated regulatory approvals. What are the major challenges you’re facing right now in vaccine development?

article thumbnail

Novartis tightens up its COVID-19 vaccine policy for staff

pharmaphorum

Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites. Novartis joins a lengthening list of pharma companies that are mandating full vaccination – at least in some developed countries like the US.

article thumbnail

How pharma companies and governments can overcome COVID-19 vaccine hesitancy

BioPharma Reporter

While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide. The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally.

article thumbnail

Cyberattack targets EMA, hacks COVID-19 vaccine data

pharmaphorum

The European Medicines Agency (EMA) says it suffered a cyberattack, with documents relating to a Pfizer and BioNTech’s COVID-19 vaccine accessed. Shortly after however BioNTech confirmed that documents submitted as part of its marketing application for coronavirus vaccine BNT-162b had been accessed by the hackers.